EntryPoint Capital LLC Increases Stock Position in Arteris, Inc. (NASDAQ:AIP)

EntryPoint Capital LLC increased its stake in shares of Arteris, Inc. (NASDAQ:AIP) by 14.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 19,814 shares of the company’s stock after purchasing an additional 2,430 shares during the period. EntryPoint Capital LLC’s holdings in Arteris were worth $202,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Needham Investment Management LLC increased its stake in Arteris by 14.7% during the 3rd quarter. Needham Investment Management LLC now owns 2,735,000 shares of the company’s stock worth $21,114,000 after buying an additional 350,000 shares during the period. Jacobs Levy Equity Management Inc. grew its stake in shares of Arteris by 36.3% in the third quarter. Jacobs Levy Equity Management Inc. now owns 253,211 shares of the company’s stock worth $1,955,000 after acquiring an additional 67,414 shares in the last quarter. State Street Corp increased its position in shares of Arteris by 18.5% during the third quarter. State Street Corp now owns 410,578 shares of the company’s stock worth $3,170,000 after acquiring an additional 64,081 shares during the period. Proficio Capital Partners LLC acquired a new stake in shares of Arteris in the fourth quarter valued at $450,000. Finally, JPMorgan Chase & Co. boosted its holdings in Arteris by 67.1% in the third quarter. JPMorgan Chase & Co. now owns 92,242 shares of the company’s stock valued at $712,000 after purchasing an additional 37,032 shares during the period. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Insider Transactions at Arteris

In other Arteris news, VP Paul L. Alpern sold 2,471 shares of Arteris stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $11.41, for a total transaction of $28,194.11. Following the transaction, the vice president now owns 64,930 shares of the company’s stock, valued at $740,851.30. The trade was a 3.67 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Saiyed Atiq Raza sold 2,776 shares of the company’s stock in a transaction on Monday, January 6th. The shares were sold at an average price of $12.34, for a total transaction of $34,255.84. Following the completion of the sale, the director now owns 684,320 shares of the company’s stock, valued at approximately $8,444,508.80. This trade represents a 0.40 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 201,936 shares of company stock worth $2,145,897. 33.70% of the stock is currently owned by insiders.

Arteris Stock Performance

NASDAQ:AIP opened at $7.09 on Friday. The firm has a market capitalization of $290.32 million, a PE ratio of -8.15 and a beta of 1.21. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.17 and a quick ratio of 1.17. The business’s fifty day moving average price is $9.22 and its 200 day moving average price is $8.81. Arteris, Inc. has a 12 month low of $5.76 and a 12 month high of $12.64.

Arteris (NASDAQ:AIP) last issued its earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.08). The business had revenue of $15.49 million for the quarter, compared to analyst estimates of $15.34 million. Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. On average, sell-side analysts anticipate that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have weighed in on AIP. Rosenblatt Securities restated a “buy” rating and set a $15.00 price target on shares of Arteris in a report on Tuesday, February 18th. Northland Securities upped their target price on shares of Arteris from $14.00 to $16.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 19th.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.